Načítá se...
Absence of mgrB Alleviates Negative Growth Effects of Colistin Resistance in Enterobacter cloacae
Colistin is an important last-line antibiotic to treat highly resistant Enterobacter infections. Resistance to colistin has emerged among clinical isolates but has been associated with a significant growth defect. Here, we describe a clinical Enterobacter isolate with a deletion of mgrB, a regulator...
Uloženo v:
| Vydáno v: | Antibiotics (Basel) |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699182/ https://ncbi.nlm.nih.gov/pubmed/33227907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9110825 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|